Skip Navigation


Annals of Oncology Advance Access originally published online on September 15, 2006
Annals of Oncology 2006 17(12):1761-1765; doi:10.1093/annonc/mdl295
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/12/1761    most recent
mdl295v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Ann Oncol
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hoffmann, M
Right arrow Articles by Raderer, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffmann, M
Right arrow Articles by Raderer, M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 European Society for Medical Oncology

hematologic malignancies

18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference

M Hoffmann1,*, S Wöhrer3, A Becherer1, A Chott2, B Streubel2, K Kletter1 and M Raderer3

1 Department of Nuclear Medicine, Medical University Vienna, Vienna, Austria
2 Department of Pathology, Medical University Vienna, Vienna, Austria
3 Department of Internal Medicine I, Medical University Vienna, Vienna, Austria

* Correspondence to: Dr M. Hoffmann, Department of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. Tel: +43 (0)1 40400 5274; Fax: +43 (0)1 40400 5552; E-mail: martha.hoffmann{at}meduniwien.ac.at

Background: The usefulness of 2-[fluorine-18]fluoro-2-deoxy-D-glucose Positron emission tomography (18F-FDG–PET) in lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is still a matter of debate, and conflicting results have been reported. We have evaluated whether the histological feature of plasmacytic differentiation (PD) might explain the heterogeneous behavior of MALT lymphoma regarding 18F-FDG uptake.

Patients and methods: A total of 35 patients with a diagnosis of MALT lymphoma referred to our PET unit were studied. Whole-body 18F-FDG–PET scans were carried out on a General Electrics advanced PET scanner 40 min after i.v. injection of 300–380 MBq 18F-FDG. Images were reconstructed iteratively. In areas with focally elevated FDG uptake, standard uptake values (SUVs) were calculated.

Results: A total of 19 patients had MALT lymphoma with plasmacytic differentiation (pMALT), while MALT lymphoma without plasmacytic features was diagnosed in 16 patients. Sixteen of 19 patients with PD showed significant 18F-FDG uptake in involved sites (SUV: 3.5–11.7). By contrast, 13 of 16 patients with normal MALT lymphoma showed a false-negative 18F-FDG–PET result. Two of these patients disclosed no tracer uptake in the majority of involved sites apart from one single lesions, while three had a true-positive 18F-FDG–PET scan (SUV: 3.4–6.0).

Conclusions: 18F-FDG–PET visualizes pMALT in a high proportion of patients, whereas FDG–PET results are significantly less reliable in typical MALT (P = 0.001). This finding may partly account for the heterogeneous results of 18F-FDG–PET-studies in MALT lymphoma.

Key words: 18F-FDG–PET, imaging, MALT lymphoma, plasmacytic differentiation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Ann Oncol:

in this issue

Ann Oncol 2006 17: 1725. [Extract] [FREE Full Text]  



This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
O. Maksimovic, W. A. Bethge, J. P. Pintoffl, M. Vogel, C. D. Claussen, R. Bares, and M. Horger
Marginal Zone B-Cell Non-Hodgkin's Lymphoma of Mucosa-Associated Lymphoid Tissue Type: Imaging Findings
Am. J. Roentgenol., September 1, 2008; 191(3): 921 - 930.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. C. Kwee, R. M. Kwee, and R. A. J. Nievelstein
Imaging in staging of malignant lymphoma: a systematic review
Blood, January 15, 2008; 111(2): 504 - 516.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
S. Wohrer, M. Troch, B. Streubel, M. Hoffmann, L. Mullauer, A. Chott, and M. Raderer
Pathology and clinical course of MALT lymphoma with plasmacytic differentiation
Ann. Onc., December 1, 2007; 18(12): 2020 - 2024.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Seam, M. E. Juweid, and B. D. Cheson
The role of FDG-PET scans in patients with lymphoma
Blood, November 15, 2007; 110(10): 3507 - 3516.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.